Clinical Trial Update: Cognitive Protection - Dexmedetomidine and Cognitive Reserve [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating on dexmedetomidine for cognitive protection in postoperative settings; terminated with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Cognitive Dysfunction
• Postoperative Delirium

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Postoperative Delirium, PD | Phase 4 | Status: TERMINATED | Results posted: 2019-07-17